{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:12:44Z","timestamp":1790986364008,"version":"4.1.0"},"reference-count":36,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2013,12,31]]},"DOI":"10.2217\/fon.13.220","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T12:16:22Z","timestamp":1386072982000},"page":"1819-1827","source":"Crossref","is-referenced-by-count":21,"title":["Romidepsin for Cutaneous T-Cell Lymphoma"],"prefix":"10.1080","volume":"9","author":[{"given":"H Miles","family":"Prince","sequence":"first","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia"},{"name":"Department of Haematology, Peter MacCallum Cancer Centre, Division Cancer Medicine, St Andrew\u2019s Place, East Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Department of Haematology, Peter MacCallum Cancer Centre, Division Cancer Medicine, St Andrew\u2019s Place, East Melbourne, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khot","sequence":"additional","affiliation":[{"name":"Department of Haematology, Peter MacCallum Cancer Centre, Division Cancer Medicine, St Andrew\u2019s Place, East Melbourne, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia"},{"name":"Department of Haematology, Peter MacCallum Cancer Centre, Division Cancer Medicine, St Andrew\u2019s Place, East Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,12,3]]},"reference":[{"key":"e_1_3_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-202895"},{"key":"e_1_3_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-390211"},{"key":"e_1_3_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2008.0033"},{"key":"e_1_3_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn095"},{"key":"e_1_3_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.01.025"},{"key":"e_1_3_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-010-9596-y"},{"key":"e_1_3_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.313"},{"key":"e_1_3_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.47.315"},{"key":"e_1_3_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20140"},{"key":"e_1_3_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.10.030"},{"key":"e_1_3_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3068"},{"key":"e_1_3_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2005.02091.x"},{"key":"e_1_3_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-025999"},{"key":"e_1_3_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6091"},{"key":"e_1_3_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0913912107"},{"key":"e_1_3_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4262"},{"issue":"8","key":"e_1_3_2_2_18_1","first-page":"1014","article-title":"Phase I study of depsipeptide in pediatric patiesis fungoides\/S\u00e9zary syndrome.","volume":"42","author":"Fouladi M","year":"2006","unstructured":"Fouladi M , FurmanW, ChinTet al. Phase I study of depsipeptide in pediatric patiesis fungoides\/S\u00e9zary syndrome. Eur. J. Cancer 42(8), 1014\u20131030 (2006).","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"e_1_3_2_2_19_1","first-page":"718","article-title":"Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.","volume":"8","author":"Sandor V","year":"2002","unstructured":"Sandor V , BakkeS, RobeyRWet al. Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin. Cancer Res. 8(3), 718\u2013728 (2002).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1215"},{"key":"e_1_3_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25584"},{"key":"e_1_3_2_2_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1693"},{"key":"e_1_3_2_2_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-312603"},{"key":"e_1_3_2_2_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.6150"},{"key":"e_1_3_2_2_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.9066"},{"key":"e_1_3_2_2_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1423"},{"key":"e_1_3_2_2_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07954.x"},{"key":"e_1_3_2_2_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.711829"},{"issue":"22","key":"e_1_3_2_2_29_1","article-title":"Characteristics of thrombocytopenia in patients treated with oral panobinostat (LBH589).","volume":"114","author":"Lin R","year":"2009","unstructured":"Lin R , HuJ, PaulSet al. Characteristics of thrombocytopenia in patients treated with oral panobinostat (LBH589). ASH Annual Meeting Abstracts 114(22), Abstract 2740 (2009).","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_3_2_2_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-318055"},{"key":"e_1_3_2_2_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2095"},{"key":"e_1_3_2_2_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1214"},{"key":"e_1_3_2_2_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0630"},{"key":"e_1_3_2_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.043"},{"key":"e_1_3_2_2_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-3144"},{"key":"e_1_3_2_2_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2434"},{"key":"e_1_3_2_3_2_1","unstructured":"National Comprehensive Cancer Network. www.nccn.org"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.13.220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:43:01Z","timestamp":1719124981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.13.220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,3]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12,31]]}},"alternative-id":["10.2217\/fon.13.220"],"URL":"https:\/\/doi.org\/10.2217\/fon.13.220","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,3]]}}}